Laboratory Corporation of America Holdings Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: October 28, 2026 results vs estimates
Laboratory Corporation of America Holdings Forecast
Laboratory Corporation of America Holdings short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 33.8% a year, a typical one-standard-deviation range is 350.64–385.68 over a week, 332.25–404.07 over a month and 243.75–492.57 over a year. (Signals as of 1 Nov 2026.)
Laboratory Corporation of America Holdings Price Chart
Laboratory Corporation of America Holdings Factors
YoY +15.1%
YoY +27.4%
YoY +32.8%
YoY +18.1%
YoY +19.5%
YoY −31.0%
YoY −13.1%
YoY −27.2%
YoY +35.1%
YoY −1.7%
YoY −8.3%
YoY −9.3%
YoY −10.1%
YoY +9.8%
YoY −7.8%
YoY −11.1%
YoY +12.5%
Laboratory Corporation of America Holdings fundamentals: income statement, balance sheet & cash flow
Laboratory Corporation of America Holdings reported revenue of $13.95bn and net income of $876.5m in FY2025, the year ended 31 December 2025 — revenue up 7.2% and net income up 17.5% on the prior year. Free cash flow was $1.21bn. These figures are as reported in the filings, not restated: 38 fiscal years and 155 quarters of history, back to December 1988. 173 FINRA short-interest settlements are published alongside them, back to June 2019.
| USD billions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 13.95 | 13.01 | 12.16 | 11.86 | 13.14 |
| Cost of revenue | 9.94 | 9.38 | 8.80 | 8.16 | 8.14 |
| Gross profit | 4.01 | 3.62 | 3.36 | 3.71 | 4.99 |
| Research & development | — | — | 0.00 | — | — |
| Selling, general & admin. | 2.22 | 2.23 | — | 2.00 | 1.95 |
| Operating income | 1.38 | 1.09 | 0.73 | 1.44 | 3.05 |
| EBITDA | 2.01 | 1.81 | 1.35 | 1.95 | 3.68 |
| Interest expense | 0.22 | 0.21 | 0.20 | 0.18 | 0.21 |
| Pre-tax income | 1.11 | 0.96 | 0.57 | 1.24 | 2.89 |
| Income tax | 0.23 | 0.21 | 0.19 | 0.23 | 0.69 |
| Net income | 0.88 | 0.75 | 0.42 | 1.28 | 2.38 |
Download Laboratory Corporation of America Holdings fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.LH.NYSE&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Laboratory Corporation of America Holdings
Explore MacroFinance macro & markets research and analysis.
Laboratory Corporation of America Holdings Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Laboratory Corporation of America Holdings; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Laboratory Corporation of America Holdings’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Laboratory Corporation of America Holdings (United States)
Laboratory Corporation of America Holdings is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Labcorp Holdings Inc.
Frequently asked questions
What is Laboratory Corporation of America Holdings?
What is the latest Laboratory Corporation of America Holdings price?
Is Laboratory Corporation of America Holdings in an uptrend?
How volatile is Laboratory Corporation of America Holdings?
What factors affect Laboratory Corporation of America Holdings?
Which trading strategies trade Laboratory Corporation of America Holdings?
How are Laboratory Corporation of America Holdings returns analysed?
Where can I download free Laboratory Corporation of America Holdings historical data?
Free Laboratory Corporation of America Holdings historical data (last 10 years)
Browse or instantly download the last 10 years of Laboratory Corporation of America Holdings daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.LH.NYSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 367.13 |
| 2026-11-19 | 368.88 |
| 2026-11-18 | 370.78 |
| 2026-11-17 | 368.24 |
| 2026-11-16 | 372.46 |
| 2026-11-13 | 370.48 |
| 2026-11-12 | 372.32 |
| 2026-11-11 | 372.23 |
| 2026-11-10 | 370.88 |
| 2026-11-09 | 371.83 |
About this stock
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.